Jasper Therapeutics, Inc. SEC filings JSPR
Jasper Therapeutics, Inc. has 483 filings in SEC EDGAR's recent list, going back to Sep 13, 2019. Its latest annual report, Form ARS, was filed on Jun 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (change to shareholder rights, bylaw or fiscal year change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Jun 15, 2026 | Dec 31, 2025 |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | May 19, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 22, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 5, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 21, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 8, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 18, 2022 | Dec 31, 2021 |
| 10-K/A | Amended annual report | Jul 19, 2021 | Dec 31, 2020 |
| 10-K/A | Amended annual report | May 24, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 30, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 26, 2020 | Dec 31, 2019 |
Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- JSPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1788028
- Former names
- Amplitude Healthcare Acquisition Corp (until Sep 29, 2021)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.